Boreal Ventures will invest in deep tech companies emerging from ÉTS Montréal’s incubator Centech and the wider Quebec ecosystem.

Proeza-backed electric truck producer Xos will list on the Nasdaq Stock Market and have an implied pro forma market capitalisation of $2bn.

Centessa has been formed as a biotech conglomerate with $250m in funding following a ten-way merger, including multiple spinouts.

Legend Capital has returned to invest in the metabolic and immunological disease-focused biotechnology developer, having backed its series A round two years ago.

MIT’s cancer and infectious disease therapy spinout has added $40m to a round that will support the progression of its lead asset into the clinic.

Xfund is among the backers of a $17m round for ImmuneID, which has been set up to commercialise research from Harvard University and Johns Hopkins University.

Commerzbank, Visa and CreditEase could be in line for exits after the card issuing platform developer confidentially filed to go public at a possible $10bn valuation.

The Progressive-backed digital banking technology provider has now secured at least $482m in total, with Russell Westbrook Enterprises leading its latest round.

The Livzon-backed cancer and infectious disease therapy developer has added $40m to a round that will support the progression of its lead candidate toward clinical trials.

Telstra and Standard Chartered Ventures helped the cloud security software provider hike its overall funding to about $185m.